Health

  • June 05, 2026

    Judge Slams Gov't For 'Pretextual' Immigration Filing Pause

    A Rhode Island federal judge ruled on Friday that U.S. Citizenship and Immigration Services' indefinite hold on processing immigration applications for individuals from the 39 countries on President Donald Trump's travel ban list is unlawful.

  • June 05, 2026

    4 Argument Sessions For Benefits Attys To Watch In June

    The Ninth Circuit will hear from a benefits administrator that claims federal law preempts state-law data breach claims, and Amazon will defend its win in a military leave bias suit at the Second Circuit. Here, Law360 looks at cases being argued in June that benefits attorneys should have on their radar.

  • June 04, 2026

    Trump Era Worse Than McCarthy For Speech, Law Dean Says

    The dean of UC Berkeley's law school told an audience of lawyers and artists on Thursday that America is experiencing "an unprecedented assault on the Constitution, on the First Amendment, and on freedom of speech," comparing the country under President Donald Trump unfavorably to the McCarthy era.

  • June 04, 2026

    Meta Says Section 230 Foils Social Media Addiction Verdict

    Meta urged a Los Angeles judge on Thursday to toss a landmark verdict against the social media giant and Google for harming a young woman's mental health, saying it deserves a total victory under Section 230 because the plaintiff was addicted to third-party content, not the platforms themselves.

  • June 04, 2026

    Generics Cos. Get More Freedom In High Court Patent Ruling

    The U.S. Supreme Court's decision Thursday shutting down a patent case involving a generic heart drug that uses a so-called skinny label establishes a road map for generics companies to avoid such suits and creates hurdles for branded companies pursuing infringement litigation, attorneys say.

  • June 04, 2026

    Eli Lilly's 'Overbroad' Weight Drug TM Deal Rejected

    A Washington federal judge has refused to sign off on a deal to settle trademark claims brought by Eli Lilly against two Seattle-area medical clinics, saying the associated consent decree was "overbroad" and contained an even more sweeping injunction.

  • June 04, 2026

    Feds Tout Medicaid Fraud Crackdown In Ohio, Slam Hawaii

    The Trump administration on Thursday praised Ohio's fight against Medicaid fraud and said Hawaii was doing too little, as federal officials pushed states to ramp up anti-fraud prosecutions or risk the loss of federal funding.

  • June 04, 2026

    ERMI Failed To Protect Patient Health Data, Class Action Says

    A medical services provider is facing a proposed class action in Georgia federal court over a 2025 data breach that allegedly exposed the protected health information of its patients, including diagnostic treatment information and provider names.

  • June 04, 2026

    Legislative Update: Cannabis And Psychedelics Bill Roundup

    New York lawmakers gave final approval to legislation designed to curb the flow of illicit product into the state's cannabis market; Iowa's governor signed into law a bill to double the number of licensed medical cannabis dispensaries; and Louisiana legislation allowing terminally ill patients to access medical marijuana became law. Here are the major moves in cannabis and psychedelics legislation from the past week.

  • June 04, 2026

    Insurers Say NY Law Firm, Providers Exaggerated Injury Suits

    Insurance companies have alleged in a new federal complaint that a New York law firm coordinated a racketeering and fraud scheme with medical providers to manufacture and inflate personal injury litigation and exploit medical treatments for profit.

  • June 04, 2026

    Cities, Doctors' Group Seek Bar On ACA Marketplace Reforms

    Several cities and groups representing doctors and small businesses urged a Maryland federal court to strike down recently finalized Affordable Care Act marketplace reforms, arguing they will strain community resources by increasing the population of underinsured and uninsured Americans.

  • June 04, 2026

    NC Doctor Seeks Probation In $11M Medicare Fraud Case

    A North Carolina doctor convicted of making false statements as part of an $11 million Medicaid fraud scheme has asked a federal judge in the state to not send her to federal prison and instead give her probation after a jury found her guilty.

  • June 04, 2026

    GAO Finds Incomplete Data Over DOD's Civilian Medical Ties

    The U.S. Government Accountability Office said Thursday that the U.S. Department of Defense's health agency hasn't sufficiently kept track of DOD partnerships with civilian medical facilities, thus impairing its ability to evaluate those partnerships and further reduce costs.

  • June 04, 2026

    CBD Oil Co., Hemp Farm Spar Over $1.7M Contract Suit

    A Washington hemp farm is suing CBD oil processor AgroRefiner LLC, alleging it breached a contract to buy 2.5 million pounds of biomass and owes $14.7 million, while AgroRefiner has filed counterclaims alleging that the biomass didn't meet the standards of the agreement.

  • June 04, 2026

    USW Drops Saint-Gobain Retiree Healthcare Change Suit

    The United Steelworkers union has dropped its lawsuit over materials manufacturer Saint-Gobain's changes to union retirees' healthcare plans, less than a week after losing a bid for a preliminary injunction and temporary restraining order.

  • June 04, 2026

    US Middle Market PE Surge Expected After Strong 2025

    U.S. middle market private equity dealmakers are signaling renewed optimism, with the vast majority expecting a meaningful jump in buyout activity over the next two years after a robust 2025, according to survey results published on Thursday. 

  • June 04, 2026

    Hogan Lovells Adds McDermott Partner In 'Pivotal Moment'

    A former McDermott Will & Schulte attorney has moved to Hogan Lovells as a partner in the antitrust, competition and economic regulation practice, the firm announced Thursday.

  • June 04, 2026

    Medical System Loses Bid To Send Data Breach Cases To Mo.

    Munson Healthcare cannot transfer two patient data breach proposed class actions to Missouri because it did not establish that Missouri courts could exercise personal jurisdiction over the healthcare system, a Michigan federal judge ruled, while ordering the provider to produce information that could determine if the cases should return to state court.

  • June 04, 2026

    Supreme Court Shuts Down 'Skinny Label' Drug Patent Suit

    The U.S. Supreme Court on Thursday ended a patent suit over Hikma Pharmaceuticals USA Inc.'s generic version of a heart drug that uses a so-called skinny label, saying Amarin Pharma Inc. had not plausibly alleged that Hikma encouraged healthcare providers to infringe its patents.

  • June 03, 2026

    AbbVie Loses Miss. Discount Drug Law Challenge For Good

    A Mississippi federal judge on Wednesday threw out a suit brought by AbbVie and other pharmaceutical manufacturers that participate in Medicaid challenging a law barring their interference with the distribution of discounted prescriptions to pharmacies serving low-income patients.

  • June 03, 2026

    Medtronic Unit Must Face Bellwether Hernia Mesh Claims

    A Massachusetts federal judge has largely cleared the way for bellwether claims in multidistrict litigation over Covidien's hernia mesh, finding that a reasonable jury could find the Medtronic subsidiary failed to adequately warn physicians about certain risks.

  • June 03, 2026

    Balwani Takes Theranos Conviction Challenge To Justices

    Former Theranos executive Ramesh "Sunny" Balwani is asking the U.S. Supreme Court to review his criminal fraud conviction and nearly 13-year prison sentence, arguing that the Ninth Circuit used the wrong review doctrine in rejecting his argument that prosecutors had failed to correct allegedly false testimony given by investor victims.

  • June 03, 2026

    DOJ Inks $56.5M Deal In Whistleblower Medicare Fraud Suits

    The U.S. Department of Justice said Wednesday that two health assessment companies and a founder of one of them agreed to pay $56.5 million to resolve whistleblower allegations that they submitted false diagnosis information to private Medicare insurers.

  • June 03, 2026

    Fla. Panel Finds Health Co. Owner Tricked Customers

    A Florida appellate court on Wednesday reversed an order clearing a health company owner of liability in a deceptive business practices case, saying the lower court wrongly found prosecutors hadn't met their burden of proof despite evidence at trial showing misconduct involving fraud. 

  • June 03, 2026

    Mass. Judge Says DOJ Trans Care Memo Suit Can Proceed

    A challenge to a Trump administration directive calling for providers of gender-affirming care to be investigated by the U.S. Department of Justice will proceed after a Massachusetts federal judge said Wednesday that the states that filed suit have already demonstrated harm from the federal government's actions.

Expert Analysis

  • 6 Issues That May Follow The 340B Rebate Pilot Challenge

    Author Photo

    Though the Health Resources and Services Administration withdrew a pending case to reconsider the controversial 340B rebate pilot program, a number of crucial considerations remain, including the likelihood of a rework and questions about what that rework might look like, say attorneys at Spencer Fane.

  • 5 E-Discovery Predictions For 2026 And Beyond

    Author Photo

    2026 will likely be shaped by issues ranging from artificial intelligence regulatory turbulence to potential evidence rule changes, and e-discovery professionals will need to understand how to effectively guide the responsible and defensible adoption of emerging tools, while also ensuring effective safeguards, say attorneys at Littler.

  • 2026 State AI Bills That Could Expand Liability, Insurance Risk

    Author Photo

    State bills legislating artificial intelligence that are expected to pass in 2026 will reshape the liability landscape for all companies incorporating AI solutions into their business operations, as any novel private rights of action authorized under AI-related statutes signal expanding exposures, say attorneys at Wiley.

  • Business Considerations Amid Hemp Product Policy Change

    Author Photo

    With the passage of a bill fundamentally narrowing the federal definition of "hemp," there are practical and business considerations that brands, manufacturers and other parties should heed over the next year, including operational strategies, evaluating contract and counterparty risk, and tax implications, say attorneys at Foley Hoag.

  • Series

    Judges On AI: How Courts Can Boost Access To Justice

    Author Photo

    Arizona Court of Appeals Judge Samuel A. Thumma writes that generative artificial intelligence tools offer a profound opportunity to enhance access to justice and engender public confidence in courts’ use of technology, and judges can seize this opportunity in five key ways.

  • Opinion

    DHS' Parole Termination Violates APA And Due Process

    Author Photo

    The U.S. Department of Homeland Security’s abrupt termination of family reunification parole programs violates both the Administrative Procedure Act and the due process rights of vetted beneficiaries who relied on the government's explicit invitation to wait in the U.S. for an immigrant visa to become available, says Abdoul Konare at Konare Law.

  • 2025's Most Notable State AG Activity By The Numbers

    Author Photo

    State attorneys general were active in 2025, working across party lines to address federal regulatory gaps in artificial intelligence, take action on consumer protection issues, continue antitrust enforcement and announce large settlements on behalf of their citizens, say attorneys at Jenner & Block.

  • Opinion

    The Case For Emulating, Not Dividing, The Ninth Circuit

    Author Photo

    Champions for improved judicial administration should reject the unfounded criticisms driving recent Senate proposals to divide the Ninth Circuit and instead seek to replicate the court's unique strengths and successes, says Ninth Circuit Judge J. Clifford Wallace.

  • How 11th Circ.'s Zafirov Decision Could Upend Qui Tam Cases

    Author Photo

    Oral argument before the Eleventh Circuit last month in U.S. ex rel. Zafirov v. Florida Medical Associates suggests that the court may affirm a lower court's opinion that the qui tam provisions of the False Claims Act are unconstitutional — which could wreak havoc on pending and future qui tam cases, say attorneys at Morgan Lewis.

  • Key Trends For Life Sciences Cos. To Watch In 2026

    Author Photo

    Following a year of drastic change at the U.S. Food and Drug Administration, two themes are likely to drive the coming year — a commitment to lowering the cost of drugs and an inherent tension between the priorities of the health agencies and the broader administration, say attorneys at Sheppard Mullin.

  • Series

    Muay Thai Makes Me A Better Lawyer

    Author Photo

    Muay Thai kickboxing has taught me that in order to win, one must stick to one's game plan and adapt under pressure, just as when facing challenges by opposing counsel or judges, says Mark Schork at Feldman Shepherd.

  • The Next Pressure Point In Digital Health: Informed Consent

    Author Photo

    Two new federal digital health initiatives will usher in a new era where virtual care, software-enabled devices and home-based monitoring are integrated into care and reimbursement models, with the impact of shifting rules and opportunities felt most immediately in the context of informed consent, says Kimberly Chew at Husch Blackwell.

  • Series

    Law School's Missed Lessons: Intentional Career-Building

    Author Photo

    A successful legal career is built through intention: understanding expectations, assessing strengths honestly and proactively seeking opportunities to grow and cultivating relationships that support your development, say Erika Drous and Hillary Mann at Morrison Foerster.

  • 4 Trends Shaping Drug And Medical Device Law For 2026

    Author Photo

    2025 saw some significant legal developments with potential impact for drug and device manufacturers, ranging from growing skepticism in science and regulatory entities to new regulation of artificial intelligence, say attorneys at Faegre Drinker.

  • Key Trends In Healthcare Antitrust In 2025

    Author Photo

    The healthcare industry braced for significant antitrust enforcement shifts last year driven by a change in administration, and understanding the implications of these trends is critical for healthcare organizations' risk management and strategic decision-making in the year ahead, say attorneys at Michael Best.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.